Dr. Kaufman is Senior Consultant within the Hematology-Oncology department at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School (Pt). He obtained his medical degree from Boston University School of Medicine and completed residency training in medicine at Bronx Municipal Hospital Center. Since completing his residency, Dr.
Aaron S. Kesselheim, M.D., J.D., M.P.H., is a Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He graduated from Harvard College and received his postgraduate training at the University of Pennsylvania School of Medicine and Law School, and most recently at the Harvard School of Public Health.
Dr. Jennifer Kesselheim attended college at the University of Wisconsin and then completed her MD degree at the University of Pennsylvania. While at Penn, she earned a Masters degree in medical ethics. As a fellow in pediatric hematology-oncology, Dr.
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology
Louise P. King, MD, JD, is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Surgeon within the Division of Minimally Invasive Gynecologic Surgery at Beth Israel Deaconess Medical Center. Dr. King completed her juris doctorate at Tulane Law School before attending medical school at University of Texas Southwestern Medical Center. She completed her residency in obstetrics and gynecology at Parkland Hospital in Dallas Texas and her fellowship in Minimally Invasive Surgery with Dr. Camran Nezhat at Stanford University.
Dr. Krakauer is Assistant Professor of Medicine and of Global Health & Social Medicine at Harvard Medical School and a practicing internist and palliative medicine specialist at Massachusetts General Hospital.
Dr. Daniel Kramer studied Philosophy at Brown University prior to earning his MD from Harvard Medical School and MPH from the Harvard TH Chan School of Public Health. He completed internal medicine training at Massachusetts General Hospital and fellowships in cardiovascular disease at clinical cardiac electrophysiology at Beth Israel Deaconess Medical Center, as well as the Medical Device Fellowship Program with the FDA. He is a member of the cardiac electrophysiology service at BIDMC.
I am the Director of the Center for Bioethics at Brigham and Women’s Hospital, associate physician in the Jen Center for Primary Care at BWH, and Associate Professor of Medicine and Global Health and Social Medicine at Harvard Medical School (HMS). The Center for Bioethics is the umbrella for ethics at BWH and I am responsible for oversight of our clinical ethics consultation service, ethics education for housestaff, hospital policy development, and bioethics research.
Doug Levy, PhD, MPH co-teaches the Methods in Bioethics course for the Master of Bioethics degree program. He received a PhD in Health Policy, Statistics and Evaluative Sciences from Harvard University and a MPH from Mailman School of Public Health, Columbia University. He is an Assistant Professor in Medicine at Harvard Medical School and co-teaches MA 750 “Medical Ethics and Professionalism”. Dr.
Rebecca Li, PhD, has over 17 years of experience spanning the entire drug development process with experience in Biotech, Pharma and CRO environments. Dr. Li currently serves as the Executive Director of the Multi-regional Clinical Trial Center at Harvard. The Center was chartered to improve the design, conduct and oversight of multi-regional clinical trials in the developing world and simplifying research through best practices. She was also a Fellow in the Division of Medical Ethics at Harvard Medical School.
Henry Isaiah Dorr Distinguished Professor of Research and Teaching in Anaesthetics and Anaesthesia
Edward Lowenstein, MD, Distinguished Henry Isaiah Dorr Professor of Anaesthesia and Professor of Medical Ethics was the Founding Chief of the Cardiac Anesthesia Group at Massachusetts General Hospital (1970). This was the first academic organization of the subspecialty and trained many of the leaders of the field. He served as Fellow of Medical Ethics in the Division of Medical Ethics 1997-8 because of an interest in end-of-life care gained in providing medical care to cardiac surgical patients. An advocate for aid in dying, he was a signatory of the narrowly defeated Massachusetts initi